Share Issue/Capital Change • Sep 20, 2007
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 20 September 2007 18:44
aap Implantate AG: Fame Medical Group Takeover Completed Successfully
aap Implantate AG / Acquisition/Capital Increase
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
aap today completed the acquisition of all shares in the Dutch FAME Holding
B.V. Group and its subsidiaries with the commercial register entry.
The capital increase by a contribution in kind agreed at the extraordinary
general meeting of aap Implantate AG held on February 15, 2007 was today
entered into the commercial register. Lawsuits filed by individual
shareholders had delayed the entry. aap thereupon embarked on fast track
proceedings, an option available since 2006 that is intended to enhance the
legal and procedural security of companies affected by lawsuits filed in
connection with shareholders’ meetings.
The register entry increases aap Implantate AG’s capital stock by EUR
8,448,999.00 to EUR 25,347,156.00, divided into 25,347,156 individual share
certificates.
Listing of the new shares for stock market trading is planned for the weeks
ahead. Due to contractual provisions 50 percent of the new shares are
subject to a 12-month lock-up period after listing.
Contact:
Bei Rückfragen wenden Sie sich bitte an:
aap Implantate AG; Nanette Hüdepohl; Investor & Public Relations; Lorenzweg
5; D-12099 Berlin
Tel.: ++49/30/750 19 – 133; Fax.: ++49/30/750 19 – 290; [email protected]
Language: English
Issuer: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: [email protected]
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Hannover, Düsseldorf, Hamburg, München, Stuttgart
End of News DGAP News-Service
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.